Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 8
2004 3
2005 10
2006 8
2007 13
2008 10
2009 13
2010 12
2011 8
2012 11
2013 11
2014 5
2015 1
2016 2
2017 1
2018 6
2019 4
2020 11
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Kishan AU, et al. Among authors: stock rg. JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587. JAMA. 2018. PMID: 29509865 Free PMC article.
Radiopharmaceuticals for Bone Metastases.
Smith AW, Greenberger BA, Den RB, Stock RG. Smith AW, et al. Among authors: stock rg. Semin Radiat Oncol. 2021 Jan;31(1):45-59. doi: 10.1016/j.semradonc.2020.07.005. Semin Radiat Oncol. 2021. PMID: 33246636 Review.
Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiation.
Stone NN, Skouteris V, Stock RG. Stone NN, et al. Among authors: stock rg. Brachytherapy. 2020 May-Jun;19(3):275-281. doi: 10.1016/j.brachy.2020.01.008. Epub 2020 Mar 23. Brachytherapy. 2020. PMID: 32217039
Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapy.
Attalla K, Sagalovich D, Marqueen KE, Sfakianos JP, Tewari AK, Badani KK, Stock RG, Stone NN. Attalla K, et al. Among authors: stock rg. Brachytherapy. 2020 Mar-Apr;19(2):210-215. doi: 10.1016/j.brachy.2019.12.002. Epub 2020 Jan 17. Brachytherapy. 2020. PMID: 31959519
Long-term oncological and functional outcomes support use of low-dose-rate brachytherapy with or without external beam radiation in young men (≤60 years) with localized prostate cancer.
Winoker JS, Omidele OO, Stock RG, Stone NN. Winoker JS, et al. Among authors: stock rg. Brachytherapy. 2019 Mar-Apr;18(2):192-197. doi: 10.1016/j.brachy.2018.12.005. Epub 2019 Jan 8. Brachytherapy. 2019. PMID: 30635196
The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapy.
Nehlsen AD, Sindhu KK, Moshier E, Sfakianos JP, Stock RG. Nehlsen AD, et al. Among authors: stock rg. Brachytherapy. 2020 Nov 13:S1538-4721(20)30221-X. doi: 10.1016/j.brachy.2020.09.018. Online ahead of print. Brachytherapy. 2020. PMID: 33199175
Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy.
Smith WH, Cesaretti J, Chin CP, Terk M, Stock RG. Smith WH, et al. Among authors: stock rg. Radiother Oncol. 2020 Oct 17;155:42-47. doi: 10.1016/j.radonc.2020.10.021. Online ahead of print. Radiother Oncol. 2020. PMID: 33075391
Factors influencing long-term urinary symptoms after prostate brachytherapy.
Stone NN, Winoker JS, Kaplan SA, Stock RG. Stone NN, et al. Among authors: stock rg. BJU Int. 2018 Nov;122(5):831-836. doi: 10.1111/bju.14365. Epub 2018 May 31. BJU Int. 2018. PMID: 29726091 Free article.
Diagnosis and management of local recurrence after low-dose-rate brachytherapy.
Stone NN, Unger P, Crawford ED, Stock RG. Stone NN, et al. Among authors: stock rg. Brachytherapy. 2015 Mar-Apr;14(2):124-30. doi: 10.1016/j.brachy.2014.08.046. Epub 2014 Sep 16. Brachytherapy. 2015. PMID: 25239396 Review.
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.
Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C Jr, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. Sandler KA, et al. Among authors: stock rg. Eur Urol. 2020 Jan;77(1):3-10. doi: 10.1016/j.eururo.2019.03.022. Epub 2019 Apr 13. Eur Urol. 2020. PMID: 30992160 Free PMC article.
121 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback